The effect of SDS micelles on reduction of toluidine blue by ascorbic acid in acid medium

Host-assisted delivery of a model drug to genomic DNA: Key information from ultrafast spectroscopy and in silico study

Intended drug delivery to a target without adverse effect is one of the major criteria for its acceptance in real use. Herein, we have made an attempt to explore the delivery efficacy of SDS surfactant in a monomer and micellar stage during the delivery of model drug, Toluidine Blue (TB) from micellar cavity to DNA. Molecular recognition of pre-micellar SDS encapsulated TB with DNA occurs at a rate constant (k1~652 s-1). On the contrary, no significant release of encapsulated TB at micellar concentration was observed within the experimental time frame. This originated from the higher binding affinity of TB towards the nano cavity of SDS at micellar concentration which doesn't allow the delivery of TB from the nano cavity of SDS micelle to DNA. Thus, molecular recognition controls the extent of DNA recognition by TB which in turn modulates the rate of delivery of TB from SDS in a concentration dependent morphology.

Unraveling the binding interaction of Toluidine blue O with bovine hemoglobin – a multi spectroscopic and molecular modeling approach

Toluidine blue O (TBO) is a cationic photosensitizer that belongs to the class of phenothiazinium dyes.

Interactions of phenothiazine drugs with surfactants: a detailed physicochemical overview

Phenothiazine drugs have been the subject of great interest due to their interesting aggregation properties and ability to interact with surfactants, model lipid bilayers, and biomembranes. Since these drugs show enormous pharmacological actions and deposits on the biomembranes, their pharmacological activities seem to be related to the drug-membrane interactions or to the absorbability on the membrane. Further, the mechanisms for the various biological activities of phenothiazines can be explained by exploring these drug-membrane interactions. Keeping these points in view, many researchers have investigated the interactions of these drugs with surfactants. This review describes the physicochemical aspects of the interactions between phenothiazine drugs and surfactants which have been discussed under three sections: (i) micellar and interfacial studies, (ii) spectroscopic studies, (iii) phase separation studies (CP) and (iv) miscellaneous.